We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Outcomes of 20 and 23-gauge Combined Transconjunctival Pars Plana Vitrectomy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01176331
First Posted: August 6, 2010
Last Update Posted: August 6, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Kocaeli University
  Purpose
In a retrospective study, a combined 20 and 23-gauge pars plana vitrectomy procedure was performed in 21 eyes for various indications and proposed as a transition procedure to 23-gauge transconjunctival vitrectomy. Through use of combination of procedures postoperative complications, surgical trauma and healing time was decreased; operating time was reduced; costs were decreased.

Condition Intervention Phase
Vitrectomy Procedure: 20 and 23 gauge pars plana vitrectomy Phase 4

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Outcomes of 20 and 23-gauge Combined Transconjunctival Pars Plana Vitrectomy

Further study details as provided by Kocaeli University:

Primary Outcome Measures:
  • visual acuity

Secondary Outcome Measures:
  • postoperative complications

Groups/Cohorts Assigned Interventions
vitrectomy Procedure: 20 and 23 gauge pars plana vitrectomy

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   44 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
Patients who were in the range 44 to 80 years, who had to undergo vitrectomy operation with different diagnosis were included in the study. Each participant had a complete ophthalmological examination which included best-corrected visual acuity (BCVA), slit lamp examination with and without pupil dilation, intraocular pressure (IOP) measurement with applanation tonometry and stereoscopic evaluation of the ocular fundus before decision of operation.
Criteria

Inclusion Criteria:

  • eyes requiring pars plana vitrectomy for various indications: such as dropped lens, intraocular blood, retinal detachments...etc.

Exclusion Criteria:

  • patients who did not observed periodically during postoperative period.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01176331


Locations
Turkey
Department of ophthalmology,Hospital of Faculty of Medicine, Kocaeli University
Kocaeli, Turkey
Sponsors and Collaborators
Kocaeli University
  More Information

ClinicalTrials.gov Identifier: NCT01176331     History of Changes
Other Study ID Numbers: KOU-8487358664
First Submitted: August 3, 2010
First Posted: August 6, 2010
Last Update Posted: August 6, 2010
Last Verified: July 2010

Additional relevant MeSH terms:
Temazepam
Hypnotics and Sedatives
Central Nervous System Depressants
Physiological Effects of Drugs
Anti-Anxiety Agents
Tranquilizing Agents
Psychotropic Drugs
GABA Modulators
GABA Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action